Reich, Kristian, Andrew Blauvelt, Diamant Thaci, Craig Leonardi, Yves Poulin, Daniel Burge, Luke Peterson, Catherine Arendt, and Alice B Gottlieb. “Maintenance of Response With Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: 48-Week Results from Two Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1 and CIMPASI-2)”. SKIN The Journal of Cutaneous Medicine 1, no. 3.1 (October 27, 2017): s23. Accessed May 16, 2022. https://www.jofskin.org/index.php/skin/article/view/125.